NCT07338357 2026-01-13
Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML
First Affiliated Hospital of Guangxi Medical University
Phase EARLY_PHASE1 Not yet recruiting
Clinical Trials
7 trialsNCT07201727 2025-10-01
CD123+CLL-1 CAR-T Sequential Infusion With CD7 CAR-T and Bridging to Allo-HSCT for Relapsed/Refractory Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Phase EARLY_PHASE1 Not yet recruiting
NCT06786299 2025-01-22
Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.
First Affiliated Hospital of Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting
NCT06702098 2024-11-22
iNK-r/r AML
Guangzhou Ruixin Biotechnological Co., LTD
Phase EARLY_PHASE1 Not yet recruiting
NCT06559644 2024-08-19
Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute Leukemia
The First Affiliated Hospital of Soochow University
Phase EARLY_PHASE1 Not yet recruiting
NCT04658004 2020-12-08
NKG2D CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Myeloid Leukemia
Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting
NCT04599543 2020-10-27
IL3 CAR-T Cell Therapy for Patients With CD123 Positive Relapsed and/or Refractory Acute Myeloid Leukemia
Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting